# EDGAR Filing Document

**Accession Number:** 0001937969
**File Stem:** 0001937969-26-000001
**Filing Date:** 2026-2
**Character Count:** 7887
**Document Hash:** 0f1da13154255565c2de828f9ab45675
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001937969-26-000001.hdr.sgml**: 20260218

**ACCESSION NUMBER**: 0001937969-26-000001

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260216

**FILED AS OF DATE**: 20260218

**DATE AS OF CHANGE**: 20260218

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Kidik Allyson M
- **CENTRAL INDEX KEY:** 0001937969

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11302
- **FILM NUMBER:** 26648668

**MAIL ADDRESS:**
- **STREET 1:** 127 PUBLIC SQUARE
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44114
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KEYCORP /NEW/
- **CENTRAL INDEX KEY:** 0000091576
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 346542451
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 127 PUBLIC SQ
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44114-1306
- **BUSINESS PHONE:** 2166896300

**MAIL ADDRESS:**
- **STREET 1:** 127 PUBLIC SQ
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44114-1306

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SOCIETY CORP
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Kidik Allyson M<br><sub>(Last) (First) (Middle)</sub><br>127 PUBLIC SQUARE<br><sub>(Street)</sub><br>CLEVELAND, OH 44114<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-16 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Auditor_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>KEYCORP /NEW/ [ KEY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Shares | 2026-02-17 |  | M |  | 4957 | A | <sup>(1)</sup> | 27029 | D |  |
| Common Shares | 2026-02-17 |  | F |  | 1730 | D | $21.69 | 25299 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2026-02-16 |  | A |  | 5184 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Shares | 5184 | $0 | 5184 | D |  |
| Option to Buy | $23.87 | 2026-02-16 |  | A |  | 5673 |  | <sup>(3)</sup> | 2036-02-16 | Common Shares | 5673 | $0 | 5673 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2026-02-17 |  | M |  |  | 478 | <sup>(4)</sup> | <sup>(4)</sup> | Common Shares | 478<sup>(5)</sup> | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2026-02-17 |  | M |  |  | 1159 | <sup>(6)</sup> | <sup>(6)</sup> | Common Shares | 1159 | $0 | 1159<sup>(7)</sup> | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2026-02-17 |  | M |  |  | 1767 | <sup>(8)</sup> | <sup>(8)</sup> | Common Shares | 1767 | $0 | 3534<sup>(9)</sup> | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2026-02-17 |  | M |  |  | 1553 | <sup>(10)</sup> | <sup>(10)</sup> | Common Shares | 1553 | $0 | 4656<sup>(11)</sup> | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

(2) These restricted stock units, granted on February 16, 2026, vest in four equal annual installments beginning on February 17, 2027.

(3) The option to buy, granted on February 16, 2026, vests in four equal annual installments beginning on February 17, 2027.

(4) These restricted stock units, granted on February 14, 2022, vested in four equal annual installments ending on February 17, 2026.

(5) Includes approximately 22 dividend-equivalent restricted stock units accrued between March and December 2025.

(6) These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

(7) Includes approximately 106 dividend-equivalent restricted stock units accrued between March and December 2025.

(8) These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.

(9) Includes approximately 242 dividend-equivalent restricted stock units accrued between March and December 2025.

(10) These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.

(11) Includes approximately 284 dividend-equivalent restricted stock units accrued between March and December 2025.

**Signature:** Adam J. Larkins POA for Allyson M. Kidik  
**Date:** 2026-02-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**